Hamid Ali Nagi Al-Jamal
Overview
Explore the profile of Hamid Ali Nagi Al-Jamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
231
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhawamdeh M, Almajali B, Hourani W, Al-Jamal H, Al-Wajeeh A, Mwafi N, et al.
Oncol Lett
. 2023 Nov;
27(1):8.
PMID: 38028180
Globally, lung cancer affected 2.2 million individuals and caused 1.8 million deaths in 2021. Lung cancer is caused by smoking, genetics and other factors. IFN-γ has anticancer activity. However, the...
2.
Ismail N, Mussa A, Al-Khreisat M, Yusoff S, Husin A, Al-Jamal H, et al.
Noncoding RNA
. 2023 Nov;
9(6).
PMID: 37987364
The dysregulation of non-coding RNAs (ncRNAs), specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), leads to the development and advancement of multiple myeloma (MM). miRNAs, in particular, are paramount in...
3.
Al-Rawashde F, Al-Sanabra O, Alqaraleh M, Jaradat A, Al-Wajeeh A, Johan M, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(6).
PMID: 37375831
The epigenetic silencing of tumor suppressor genes (TSGs) is critical in the development of chronic myeloid leukemia (CML). functions as a TSG and negatively regulates JAK/STAT signaling. Enhancement of expression...
4.
Alshwaiyat N, Ahmad A, Al-Jamal H
Front Nutr
. 2023 Jun;
10:1155947.
PMID: 37284649
Introduction: Obesity and iron deficiency are prevalent health problems that affect billions of people all over the world. Obesity is postulated to relate to iron deficiency via reduced intestinal iron...
5.
Saad H, Taib W, Ab Ghani A, Ismail I, Al-Rawashde F, Almajali B, et al.
Diagnostics (Basel)
. 2023 Apr;
13(7).
PMID: 37046464
Background: β-thalassaemia is a disorder caused by mutations in the β-globin gene, leading to defective production of haemoglobins (Hb) and red blood cells (RBCs). It is characterised by anaemia, ineffective...
6.
Al-Rawashde F, Al-Wajeeh A, Vishkaei M, Saad H, Johan M, Taib W, et al.
Pharmaceuticals (Basel)
. 2022 Sep;
15(9).
PMID: 36145344
Constitutive activation of Janus tyrosine kinase-signal transducer and activator of transcription (JAK/STAT) and Phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathways plays a crucial role in the development of acute...
7.
Almajali B, Johan M, Al-Wajeeh A, Taib W, Ismail I, Alhawamdeh M, et al.
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337104
Overexpression of c-Myc plays an essential role in leukemogenesis and drug resistance, making c-Myc an attractive target for cancer therapy. However, targeting c-Myc directly is impossible, and c-Myc upstream regulator...
8.
Saad H, Abd Rahman A, Ab Ghani A, Taib W, Ismail I, Johan M, et al.
Biomedicines
. 2022 Jan;
10(1).
PMID: 35052868
Iron homeostasis is regulated by , a hepatic hormone that controls dietary iron absorption and plasma iron concentration. binds to the only known iron export protein, ferroportin (FPN), which regulates...
9.
Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells
Al-Rawashde F, Taib W, Ismail I, Johan M, Al-Wajeeh A, Al-Jamal H
Asian Pac J Cancer Prev
. 2021 Dec;
22(12):3959-3965.
PMID: 34967577
Objective: BCR ABL oncogene encodes the BCR-ABL chimeric protein, which is a constitutively activated non-receptor tyrosine kinase. The BCR-ABL oncoprotein is a key molecular basis for the pathogenesis of chronic...
10.
Al-Rawashde F, Johan M, Taib W, Ismail I, Tuan Johari S, Almajali B, et al.
Pharmaceuticals (Basel)
. 2021 Dec;
14(12).
PMID: 34959687
Epigenetic silencing of tumor suppressor genes (TSGs) plays an essential role in cancer pathogenesis, including acute myeloid leukemia (AML). All of , , and are TSGs that negatively regulate JAK/STAT...